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1. 1976 was full of excitement 
 
In 1974, after reading Dr. Marshall Nirenberg’s paper on glioma and 
neuroblastoma cells (Amano et al., 1972), I wrote him a letter stating that I 
wanted to work with him as a post-doctoral fellow. I had previously studied 
membrane properties and potassium ions in neurons and glia cells in the rabbit 
cortex (Higashida et al., 1974). He responded to me in a letter with one sentence 
stating, “send me recommendation letters”. After sending three letters, I patiently 
waited for his response, but there was none. I then asked Toshiharu Nagatsu, 
Marshall’s friend who worked in the same laboratory (that of Udenfriend) at the 
National Institutes of Health from 1962-1964 (Nagatsu et al., 1964), to ask 
Marshall about the possibility of me obtaining a postdoctoral position in his 
laboratory. Then I received a response. Later, I learned that he rarely wrote 
letters and he only trusted the references of a few people. Nagatsu was one of 
his trusted friends, and once I met Marshall in 1976, we collaborated together 
intermittently for 35 years until just before his death on January 15, 2010. I 
believe that we formed a very personal bond. 
 In 1976, I started my post-doctoral training in the laboratory of Dr. 
Marshall Nirenberg. The first day I met Dr. Nirenberg was Monday, May 4, 1976. 
I waited for him to come into the laboratory since that morning, but he did not 
arrive until noon, which was usual at that time. Marshall attended the Monday 
lunch seminar in the laboratory library, but I did not recognize him. After the 
seminar, I had a chance to talk to him. When I saw Marshall in his office, which 
contained many books, journals, experimental notebooks and published articles, 
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although 49 years old, I thought he still looked young. There were only tiny 
spaces left around his desk and a path to his chair. Important information on 
experimental results, such as the properties of clonal cells, in bound files made 
10-15 years before, was located exactly within reaching distance. On the shelf, 
there were many half-filled Coca-Cola cans.  
At that time, many fellows engaged in electrophysiological research, 
including myself. Marshall introduced me, but not the other fellows, to Drs. Philip 
Nelson and Bruce Ransom who is now professors of Neurology at the University 
of Washington in Seattle. I observed them for 2 weeks to learn how to use both 
hands to handle the manipulators used to penetrate cultured neuroblastoma x 
glioma hybrid NG108-15 cells with microelectrodes under a phase-contrast 
microscope. It was necessary to train my left hand to move the microscope 
stage and penetrate presynaptic cells with a microelectrode. Furthermore, my 
right hand was trained to focus on cells, including post-synaptic muscle cells. At 
that time, other post-doctoral fellows who performed electrophysiological 
analyses quickly mastered recording miniature endplate potentials from cultured 
myotubes using the complete electrophysiological setup. Within 6 months, they 
could obtain meaningful data. In contrast, I first disconnected the wires from my 
setup and reconnected them from a preamplifier to a main amplifier, a pen 
recorder and a tape recorder. It took me 5 months to master the use of the 
recording system on cultured cells, and Marshall patiently watched my slow 
progress. 
I was first able to detect MEPPs in co-cultures of NG108-15 cells and 
myotubes in September of 1976, which confirmed results in his laboratory, 
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originally obtained in the Nelson laboratory, of Marshall’s own young fellow 
completely outside this field. Marshall always required confirmation of published 
data by a newcomer or that of ongoing data by mutual confirmation by 2 fellows 
in different rooms at the same time.  
The year of 1976 was exciting in the Marshall laboratory because he 
achieved one of his goals in his neurobiological studies (Table 1). Ten years 
prior, he had decided to use neuronal tumor cells as a tool to decipher memory 
processes in the brain. Cell-cell interaction (recognition) was succeeded by in 
vitro functional cholinergic synapse formation between neuroblastoma x glioma 
hybrid cells and two different types of post-synaptic cells: primary muscle cells, 
which was observed in January (Nelson et al., 1976), and G-8 clonal muscle 
cells, which was observed in May (Christian et al., 1976).  
The laboratory was full of excitement and activity. Every postdoctoral 
fellow waited in front of Marshall’s office to discuss their new data that they 
wanted to publish in the Proceedings of the National Academy of Sciences. 
Marshall and each fellow often stayed in the laboratory without sleep on the 
night before the PNAS deadline each month to complete the final draft of their 
paper. The laboratory technician would rush to the PNAS office in downtown 
Washington, DC, to submit the final version of the paper on the day of the 
deadline. Once, Marshall said to me that submitting a PNAS paper with a limited 
number of words and printed pages is like writing a “Ha-i-ku”, a Japanese poem 
composed strictly of 17 (5+7+5) Japanese characters. 
 
2. Initial screening of neuroblastoma cells as presynaptic elements 
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 Marshall’s aim was to screen presynaptic elements for synapse 
formation capacity using 21 clonal cells or hybrid cells selected from his huge 
stock collected at the beginning of experiments (Table 2). Steve Wilson 
measured choline acetyltransferase activity and acetylcholine (ACh) content, 
and I measured ACh release in functional synapses identified by the presence of 
miniature or evoked endplate potentials in co-cultured myotubes. We tested 3-5 
new clones per month. However, we obtained negative data for 6 months. This 
project seemed to be misguided in everyone’s eyes. However, on May 5, 1977, I 
measured thousands of synaptic responses for more than 30 min from a 
myotube cocultured with NBr-10A (N18TG-2 x Bufferlo rat liver cell) hybrid cells. 
I rushed to Marshall’s room where he was talking with Klee, and both came to 
watch the synaptic activity. In the same week, Wilson obtained a huge release of 
ACh from NBr-10A cells in response to high potassium (Table 2). 
In May 1977, I determined that MBr10A cells were better than NG108-15 
cells with respect to synapse formation, 1 week before the birth of my son. I 
stopped working for 1 week to take care of my wife and children without telling 
Marshall and the other people in the laboratory. When Marshall wanted to 
discuss the positive data, he was uncomfortable and slightly angry about my 
absence. This was the only time he showed emotion to me.  
In some ways, synapse formation paralleled the ability to synthesize the 
ACh. However, the parallel was incomplete. Cells with higher synthetic ability 
formed more synapses, but many other cells with choline acetyltransferase 
activity did not form synapses (Nirenberg et al, 1983a and b). It appeared that 
additional factor(s) controlling ACh release remained undiscovered.  
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 A clue to the missing factors was obtained 20 years later by researchers 
in Gif, France. In 1995, when I examined the ACh release capacity of 
ACh-deficient clones overexpressing choline acetyltransferase, I observed that 
there were two types of cells: those that can form synapses (ACh release+) and 
those that cannot (ACh release-) (Zhong et al, 1995a and b). The representative 
clones of the former and latter are Neuro2A and N18-TG2 neuroblastoma cells, 
respectively. In 1996, a French group determined that a 16-kDa proteolipid, a 
mediatophore in Tordedo electric organs (Israel et al., 1987), mediates 
Ca2+-dependent ACh release from N18-TG2 neuroblastoma cells in which 
choline acetyltransferase and a mammalian ortholog, the c-subunit of the V0 
sector of vacuolar proton ATPase (ATP6V0C; Di Giovanni et al., 2010), are 
exogenously expressed (Falk-Vairant et al., 1993). They pointed out that the 
capacity for synapse formation in NG108-15 cells derives from C6BU-1 glioma 
cells because ACh was released after the glioma cells were soaked in ACh 
solution, and C6BU-1 cells possess endogenous ATP6V0C and can release 
ACh. Marshall would not be so happy if the difference in synapse formation 
capacity could be partly explained by a property derived from glioma cells with 
ATP6V0C and not from neuroblastoma cells. However, this system was recently 
utilized to show that dopamine can be released from N18 cells with ATP6V0C 
and from NG108-15 cells, and that ATP6V0C mediates dopamine release in the 
lesioned striatum in hemi-Parkinsonian model mice (Jin et al., 2012, in this 
issue), indicating that ATP6V0C is a potential gene therapy agent for 
Parkinson’s disease.  
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3. Finding the best combination of PGE1 and theophylline for cell 
differentiation 
Marshall did much work to measure adenylyl cyclase activity and 
intracellular levels of cyclic AMP (cAMP) and cyclic GMP, which were the 
essential aspects of hormonal signal research at the time (Matsuzawa, 1975; 
Sharma et al., 1975) even after Gilman left for Charlottesville, Virginia, in early 
1970 (Gilman and Nirenberg, 1971). Marshall reached his favorite working 
hypothesis for opiate tolerance and dependence by showing the time course of 
sensitization and desensitization of adenylyl cyclase upon exposure to opiates, 
resulting in increases and decreases in cAMP content (Sharma et al., 1975). He 
seemed to keep this model as a model of memory or cellular memory of neurons. 
In 2009, based on this hypothesis, he identified enhancers of long-term memory 
via their activation of the cAMP responsive element binding (CREB) protein 
signaling pathway using a high-throughput screening format (Xia et al., 2009 and 
2011).  
In 1976, synapse formation was induced by dibutyryl cAMP-mediated 
functional differentiation in culture medium. In March of 1978, Marshall wanted 
more efficient cell differentiation agents to elucidate cAMP-dependent cell 
differentiation.  
In August of 1978, Marshall suddenly got sick with very severe pain from 
gallbladder stones. He was admitted to the suburban hospital near our building 
(36) in the northeast corner of the NIH campus. Marshall continued to work 
during the night. He usually carried two folders in his arms, full of the day’s  
papers and documents, and he went back to his house at around 5 or 6 o’clock 
 8 
in his convertible with his wife, Perola. He would read these papers until late and 
fall sleep in the early morning. He did not look so strong but rather pale. We were 
very anxious to know if he suffered from an associated gallbladder tumor, but 
that was not the case. Due to his life style, whenever he came to Japan, he 
would say that he could easily adapt to the jet lag because he had lived in the 
United States on Japanese time.  
When we visited him in the hospital after his operation, he smiled when 
he heard the results regarding PGE1 and theophylline (Nirenberg et al., 1983a 
and b; Higashida, Wilson, Keninner and Nirenberg, unpublished data).  
 
4. Screening peptide receptors in NG108-15 cells  
In the fall of 1977, Marshall showed me a new idea of his and asked me 
to try receptor screening in NG108-15 cells using electrophysiology. This 
method was used to measure membrane potential changes in response to 
peptides, and it seemed to have advantages over the biochemical assay with 
each radio-labeled ligand because the electric responses could be obtained in 
real time 1-2 min after the application of current to cells.  
In 1977, A.V. Schally, R. Guillemin, and R.S. Yalow shared the Nobel 
Prize for identifying and assaying new hormones extracted mammalian tissues. 
At that time, it was beginning that peptide hormones were synthesized by a 
Beckman’s peptide synthesis apparatus, and then synthetic hormones had 
become commercially available. Marshall was attracted to this convenient way of 
screening for peptide receptors, which were not known in neuroblastoma cells.   
He made a list of more than 30 peptides to be tested using Sigma 
 9 
catalog-type experiments. Most of the agents showed no response, with the 
exception of neurotensin, angiotensin II and bradykinin. Although bradykinin was 
not included in Marshall’s original list, I added it because I was familiar with this 
pain-inducing peptide in my graduate work in Nagoya, Japan. We concluded that 
vasoactive peptides induce transient hyperpolarization followed by prolonged 
depolarization (Higashida et al., 1986), and no electrical responses were elicited 
by peptides that preferentially couple to adenylyl cyclase. However, at that time 
we did not know the mechanism by which these three agents produce such a 
complex pattern of membrane potential changes. I speculated that such complex 
sequential changes could be explained by cAMP, but by a different mechanism. 
  
5. Novel signal transduction via phosphoinositide turnover 
Six years later, in 1983, the above question was answered by my own 
effort with Yano and Nozawa from the Gifu University School of Medicine from 
which I graduated. Nozawa, a lipid biochemist, was interested in muscarinic ACh 
receptors (mAChRs), which were expected to couple to phospholipase C 
because Hokin in Canada (1953) and Michell (1975) and Berridge (2009) in the 
UK found diacylglycerol and inosito-1,4,5-trisphosphate as possible second 
messengers. Because I had neuroblastoma cells in culture in Japan, after 
completing my post-doctoral training in 2.5 years, we instantaneously performed 
experiments on lipid turnover in neuronal cells. Even though NG108-15 and 
N1E-115 neuroblastoma cells possess mAChRs, as shown in the dramatic 
elevation of cyclic GMP by carbamylcholine (Matsuzawa and Nirenberg, 1975), 
we struggled without results for 2-3 months. We then examined bradykinin 
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because I knew that these cells showed electrophysiological responses to this 
agent. The PI turn over was clearly elevated by bradykinin, and we published 
this result in the Journal of Biological Chemistry (Yano et al., 1984). This was the 
5th example of receptor-mediated elevation of PI turnover, and of course the first 
report of this elevation by bradykinin (Berridge, 1986).  
We later determined why ACh had no effect on PI turnover. When genes 
for receptors were found and cloned in the 1980s, each receptor consisted of 
several subtypes, revealing that NG108-15 hybrid cells and other clonal cells 
express only one receptor subtype, which was a surprise to all of us. NG108-15 
and N1E-115 cells possess the m4 subtype of mAChRs (Fukuda et al., 1988), a 
finding confirmed by me, Fukuda, and Numa at Kyoto University, who obtained 
numerous genes encoding membrane elements in neurons, such as nicotinic 
and muscarinic acetylcholine receptors, voltage-dependent sodium and calcium 
channels, ryanodine receptors and GTP binding proteins (Numa et al., 1988; 
Numa, 1987-1988).  
Based on our signal transduction studies, the m1 and m3 subtypes 
couple to phospholipase C and PI turnover and result in membrane potential 
changes. However, the m2 and m4 subtypes are selectively coupled to adenylyl 
cyclase. Therefore, these subtypes do not result in the activation of 
phospholipase and do not cause membrane changes (Fukuda, 1988). 
Consistent with this, in the initial experiment on NG108-15 cells, we observed no 
response with ACh.  
In addition to synapse formation capacity, NG108-15 cells showed 
strong intracellular signal responses via intrinsic receptors. For a long time, 
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NG108-15 cells and other clonal cells were used to analyze the signals from 
intrinsic receptor subtypes. However, starting in 1988, I used NG108-15 cells to 
overexpress or transform extrinsic genes after transfection (a heterologous 
expression system). At that time, Marshall stopped using NG108-15 cells, 
although such new applications interested Marshall. He carefully stored his cells 
and answered requests for them for different purposes from all over the world.  
 
6. Revolutionary idea of cloning neuronal tumor cells and hybrid cells 
Marshall Nirenberg introduced a method for cloning cells commonly 
used in bacteriology to the study of mammalian neurons after decoding genes. 
Studying mammalian neuronal cells with a uniform genetic background was not 
seriously considered before Marshall’s project, and this approach enabled us to 
characterize biochemical and pharmacological properties and the regulation of 
neurotransmitters, receptors, ion channels, and intracellular signal transduction. 
Thus, Marshall helped to found the new field of neurobiology. This cloning 
technique has been popular since its inception (Amano et al., 1972).  
Starting in 1970, Marshall showed much interest in somatic cell hybrids 
as mentioned above (Table 1). I think Marshall thought he could dissect several 
neuronal properties in the developmental process. He produced hybrid cells to 
dissect their neuronal properties via a collaboration with H. G. Coon at the 
National Cancer Institute. John Minna, who was in Marshall’s laboratory until 
1976, and Marshall used hybrids between neuroblastoma and fibroblast cells 
(Minna et al., 1971) and proposed the following differentiation stages from 
primitive to mature neurons: neurite extrusion (morphological aspect), type B 
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currents (K channel properties), type A currents (sodium channels) and 
cholinergic properties with choline acetyltransferase. The expression sequence 
in development can tell us which neuronal properties are the most critical (Minna 
et al., 1972). Unfortunately, additional information such as the chromosomal 
location of these properties was not obtained because most hybrid cells possess 
tetraploid chromosomes that are a mixture of mice and rats (Kano-Tanaka et al., 
1982; Higashida et al., 1985). 
 
7. Dopaminergic clone 
Another disadvantage of Marshall’s clonal cells was that he failed to 
obtain true dopaminergic cells. He selected adrenergic clones due to tyrosine 
hydroxylase activity (Amano et al., 1972) because he belonged to one section of 
the Udenfriend laboratory. Udenfriend, Nagatsu and Perola Zaltmann-Nirenberg 
(who came from Brazil and spoke Portuguese) characterized tyrosine 
monooxygenase (hydroxylase) as the first step in tyrosine metabolism to 
adrenaline (Nagatsu et al., 1964; Udenfriend et al., 1965). As a result, tyrosine 
hydroxylase was very familiar to Marshall and Perola. Later, it became clear that 
these clones lacked the necessary enzymes to make dopamine, noradrenaline 
and adrenaline. Therefore, these clones were imperfect adrenergic cells.  
However, a more suitable PC12 pheochromocytoma clone with dopamine 
release was introduced by Lloyd Greene, an alumnus of Marshall’s laboratory 
(Greene and Tischler, 1976).  
In 2000-2001, when the big question of how to use stem cells in 
medicine arose, Marshall said, “the basic idea of using dopaminergic clonal cells 
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in transplantation therapy for Parkinson’s disease has already been shown 
30-40 years ago in my research”.  
 
7. Cell-cell recognition by monoclonal antibodies 
In 1976, cell-cell interactions were the topic in Marshall’s laboratory 
(Table 1), because two different cells form a synaptic connection (Nelson et al., 
1976). Usually, heterophilic recognition (e.g., in liver and brain cells) is inhibited 
to promote aggregation. Synapse formation is a typical means of cell recognition. 
Sperry’s hypothesis (1963) of the chemical gradient was interesting even to 
Marshall (Goolsby et al., 2012, in this issue). 
In 1975, when Milstein published his technique for making hydridoma 
cells, which were made by fusing proliferating myeloma cells with antibody 
producing cells (Kohler and Milstein, 1975). Frank Walsh arrived in Marshall's 
laboratory in 1977 from London and brought with him an understanding of the 
new monoclonal antibody technology having heard the Milstein’s lecture there. 
Marshall immediately saw the importance and potential of the method to identify 
cell-cell recognition molecules and this started a major new research area for the 
laboratory for a number of years, 7 years prior Milstein being awarded the Nobel 
price in 1984. His idea was to obtain monoclonal antibodies against neuronal 
surface molecules such as calcium channels and neurotransmitter receptors. 
These antibodies became useful for characterization of membrane proteins and 
cloning genes encoding. Therefore, Marshall immunized mice with 
neuroblastoma whole cell surface membranes as antigen instead of purified 
protein. Many hybridoma cells were established in this way but have remained 
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uncharacterized. 
In 1980, Marshall was invited to the 23rd annual meeting of the Japanese 
Society for Neurochemistry, and when he came he asked me to come back and 
work with him on screening monoclonal antibodies for the following functional 
responses in dynamic synapses in culture: an increase or decrease in MEPP 
frequency. Within the 3 months from December 1980 to February 1981, I 
screened >20 monoclonal antibodies and classified them into 3 groups: those 
that increase or decrease MEPP frequency and ineffective antibodies. I 
presumed he wanted to find an antibody for voltage-dependent Ca2+ channels. 
Although we examined them extensively, most of the monoclonal antibodies 
raised from neuroblastoma cell surface membrane antigens turned out to 
recognize sugar moieties (glycoproteins) rather than a specific protein. Thus, all 
the results on monoclonal antibodies against neuroblastoma cells have 
remained unpublished. This was a sharp contrast from neural retina neurons, in 
which many interesting antibodies were reported (Eisenbarth et al., 1979; Trisler 
et al., 1981; Nirenberg et al., 1983a and b). 
 
9. Bradykinin receptor signaling 
When I recall being invited for the third time to work in Marshall’s 
laboratory from 1984 to 1987, I always keep the following story in mind: Echu, 
the emperor’s teacher and a Buddhist priest in China, called his attendant three 
times. The attendant responded three times. Echu said, “I thought I was the 
World-Honored One, now I realize that you too are the World-Honored One”. Of 
course, I thought Echu was Marshall and that I was the attendant. 
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This time Marshall and I agreed to work on signal transduction 
downstream of bradykinin receptors. One day he introduced me to a resident 
scholar at the NIH, David A. Brown from University College London. We worked 
on the electrophysiology of cultured cells. Brown and I obtained enough data to 
show that bradykinin-receptor-induced membrane excitation occurs due to the 
closure of voltage-dependent time-independent potassium M-currents 
(Higashida and Brown, 1986). Thereafter, we worked together on the 
mechanism of IP3 and protein kinase C, and we proposed that these secondary 
messengers are responsible for biphasic membrane currents (Brown and 
Higashida 1988). Later, this hypothesis was applied to mACh receptors (Fukuda 
et al., 1988). 
Using pertussis toxin, I, Klee and Nirenberg suggested that bradykinin 
receptors use the Gi or Go GTP binding proteins to couple to phospholipase C in 
signal transduction (Higashida et al., 1986). Unfortunately, this suggestion later 
turned out to be not completely correct (Taussing et al., 1992), although 
bradykinin receptors were determined to couple to pertussis toxin-sensitive G 
proteins. Pertussis toxin-insensitive Gq/11 G proteins were not known at that 
time, which could be one reason that this suggestion may have been incorrect 
(Smrcka et el., 1991; Taylor et al., 1991). However, our work stimulated a field of 
research on the links between signaling molecules and membrane currents.  
   
10. The best image of a real scientist 
Around 1985, Marshall tried to clone genes for Gαs proteins and Gαi G 
proteins (Bray et al., 1986 and 1987). He read amino acid sequences by 
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translating nucleotide sequences using a genetic code table. I frequently saw 
him through the open door of his room trying to do this. At that time, every 
researcher manually translated each triplet to an amino acid using this table. 
Every researcher in the molecular and biochemical fields owes him for this 
discovery, and he also used his code table in his gene cloning research. I 
thought to myself, “This is science!”  
At that time, Marshall tried to clone bradykinin receptors. As a first step, 
he proposed to purify bradykinin receptors using [S35]GTP-γ-S as a probe. He 
thought bradykinin receptors expressed in NG108-15 cells could be pulled down 
as radiolabeled GTP, G protein and bradykinin receptor complexes that could be 
trapped in filters (Figure 1), which is one of his favorite methods. Then, we could 
make a bradykinin receptor antibody or determine a partial bradykinin receptor 
amino acid sequence for gene cloning. He proposed that [Ca45] release from 
HEK cells expressing bradykinin receptors from the transfection of candidate 
cDNAs could be used for characterization in multi-well plates. Unfortunately, the 
postdoctoral fellow from Japan who used this functional gene cloning method 
was not successful. However, a similar functional cloning strategy was 
successfully applied to capsaicin–receptor ion channels (Caterina et al., 1997).  
  
11. Genome-wide screening for synapse-forming genes in fruit flies 
The last project I worked on with Marshall was genome-wide screening 
for genes related to heart and neuron development using RNA interference 
(Ivanov et al., 2004; Koizumi et al., 2007). Marshall applied for a special grant 
from the National Heart, Lung, and Blood Institute and received money to initiate 
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genome-wide research in Drosophila embryos 2 years later than the discovery of 
RNAi by Fire and Mello (Fire et al., 1998), who won the Nobel Price in 2006. 
When I joined this project in June 2001, double-stranded RNA solutions were 
already in his hand. Three different solutions were mixed for injection into fly 
embryos to facilitate the screening. However, we later switched to testing each 
RNA solution in 100-200 fly embryos. This was my first time studying the 
Drosophila genome. Marshall taught me himself, and together we studied the 
neural structures in embryos. At first, I selected too many genes that destroy the 
formation of the central and peripheral nervous systems.  
On September 11, 2001, terrorists attacked the World Trade Center in 
New York and the Pentagon in Washington, DC. At the end of September, 
Perola died after suffering from Alzheimer’s disease. Approximately 10 years 
previously, her disease was first recognized by an impairment in her spoken 
English, her second language. She was cared for in their home by a nurse 
during the day and by Marshall at night. There was a funeral for her, but 
unfortunately I could not attend because I had to go back to Japan on a 
scheduled flight. And if I missed this flight, it would have been very difficult to 
arrange another flight. After the terrorist attack, there was a lot of confusion 
everywhere, especially on airplane flights. I briefly expressed my sincere 
condolences about her death to Marshall and left for Japan. In Japan, I slowly 
built up my fly research unit, continuing the project by myself with shared RNA 
solutions.  
 Before screening >5800 genes, I visited Marshall once or twice a year. 
During this period, he bought a new house in Potomac, Maryland, and he was 
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kind enough to let me stay in his house every time, which was a surprise to me 
at first. One reason he allowed me to stay was because of his marriage to Myrna 
Weissman, a professor at Columbia University who lives in New York. She is 
very energetic and open-minded . One time in 2002, Marshall told me about his 
idea of getting married again and asked me about the efficiency of my life style, 
living in two cities. After discussed with my wife, I remember answering that if 
you feel you are happy, then it is okay and there is no problem at all living 
separately during the weekdays and together on the weekend. I lived this way 
for more than 30 years with very little trouble. I believe that Marshall gained a 
vivid life surrounded by in-law family members, similar to how he lived in his 
younger days in Florida. 
 He also moved to his old location on the 7th floor in corridor D of Building 
10, the main NIH building. I heard that he had moved to the same location in 
which he had conducted research on the genetic code. He used half of a room 
for his own office at his request.  He didn't feel he needed all the space he 
had to do his work and didn't want to see it wasted when other scientists might 
be able to use it. He was quite content to have a small office. His new laboratory 
was downsized to one-third the size of his old laboratory in Building 36, where he 
used two floors (received after being awarded the Nobel price) and kept all kinds 
of supplies and constantly refilled chemicals. The liquid nitrogen for keeping 
culture cells was maintained by two technicians, and 4-5 secretaries were 
always in his office.   
 
12. New studies on social memory and autism 
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 In 2003, I published an article on the mechanism by which Kv7.2 
(M-type) potassium channels are closed by protein kinase C and the A-kinase 
anchoring protein in response to ACh (Hoshi et al., 2003). Based on this 
publication and suggestions for faculty development by Marshall and Myrna, I 
was awarded a sizable grant from the central government at the Kanazawa 
University Center of Excellence Program on Innovative Brain Science on 
Learning, Memory and Development. In this program, I focused on social 
cognition, memory and autism spectrum disorders. When I examined male 
behavior in CD38 knockout mice, males showed impaired social memory in the 
form of amnesia regarding mates from previous encounters (Jin et al., 2007; 
Higashida et al., 2010). Two single nucleotide polymorphisms in human CD38 
were determined to be associated with autism spectrum disorder (Munesue et 
al., 2010).  
 Additionally, I further characterized two genes, Robo and Pebble, which 
were identified as strong candidates for involvement in synapse formation in 
Drosophila embryos by the RNAi whole-genome project (Ivanov et al., 2003; 
Koizumi et al., 2007). Expression of the axon guidance receptors ROBO1 and 
ROBO2 was significantly reduced in the lymphocytes of an autistic group (Anitha 
et al., 2008) and in the anterior cingulate cortex and primary motor cortex of 
postmortem brains of autistic humans (Suda et al., 2011). My daughter, who met 
Marshall frequently from 3 to 5 years of age at the NIH kindergarten, and I 
showed that the Rho guanine nucleotide exchange factor Ect2, an ortholog of 
Drosophila Pebble, negatively regulates neurite outgrowth in neuroblastoma × 
glioma hybrid NG108-15 cells, and that this protein is expressed in the 
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developing mouse pituitary gland (Islam et al., 2010; Tsuji et al., 2011). The 
seeds sown by Marshall for deciphering brain memory are still growing here with 
regard to social memory and autism, which is one of the major topics in the 
2010s. 
 
 Now Marshall takes his everlasting sleep in Sharon Garden, a Jewish 
cemetery in Valhalla, Westchester County, New York. His grave reads, “Marshall 
Warren Nirenberg. 1927–2010. A titan of science. A man beloved. He 
deciphered the genetic code and showed that all living things are related. Nobel 
Laureate Medicine and Physiology, 1968.” Myrna and I visited his new grave on 
July 27, 2011. I prayed for him by flattening my hands in the Japanese style, and 
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Table 1 Transition of Nirenberg’s targets and interests in1970s of the 
post-genetic-code era. 
Year 1967-  1970-   1973-  1976- 
 
Method Cloning  Somatic cell hybrid Co-culture Hybridoma 
 
 
Targets Genetically Differentiation  Synapse  Monoclonal 




Interests Neuro-  Developmental  Cell-cell  Chemical 




Table 2. Acetylcholine synthetic activity and synapse formation in myotubes&  
 
Cell lines  Parental clones  Choline acetyltransferase Synapse  
     (pM [14C]ACh formed formation (%) 
     /min/mg protein) 
 
NBr-10A  N18TG-2* x BRL-30E** 201   65 
NG108-15 N18TG-2 x C6BU-1*** 191   55 
NBr20A  N18TG-2 x BRL-30E 188   40 
NCB20  N18TG-2 x CHEC#  37   20 
SB37A  N18TG-2 x NS-20TG11-E* 178   14 
NS20Y  Neuroblastoma clone 245    6 
NG108-05 N18TG-2 x C6BU-1 349    6 
NS27B  Neuroblastoma clone 168    4 
N4G-Ba  N4TG-3* x C6BU-1 386    3 
N4G-Ca  N4TG-3 x C6BU-1 463    1 
 
N4G-Cb  N4TG-3 x C6BU-1 182    0 
SB37B  Neuroblastoma clone 152    0 
SB53B  Neuroblastoma clone 72    0 
SB76B  Neuroblastoma clone 61    0 
SB21B  Neuroblastoma clone 34    0 
SB50A  Neuroblastoma clone 22    0 
SB79A  Neuroblastoma clone 22    0 
SB501A  Neuroblastoma clone 22    n.d. 
SB66B  Neuroblastoma clone 10    0 
SB602A  Neuroblastoma clone  5    0 
NBr9A  N18TG-2 x BRL-30E  5     0 
& Taken from unpublished data of Wilson, Higashida, Adler and Nirenberg and Nirenberg et al., 
1983a and b. *Neuroblastoma clones; ** Buffalo rat liver cells; ***rat glioma cells: #Chinese 








Fig, 1. One of hand-writing protocols, showing his idea of purification of bradykinin receptors (BK 
and R). A bottom cartoon represents the filter trap method, one of Marshall’s favorite methods, 
which were used in studies of protein synthesis from synthetic mRNAs and adenylyl cyclase 
activity. α,γ,β, subunits of GTP binding proteins; GTPγS, non-hydrolysable GTP; S35 Ca45, 
isotopes of sulfide and calcium as tracers. 

